Registered Nurse Immunisation Authority
POISONS AND THERAPEUTIC GOODS ACT 1966
Authorisation to Supply Poisons and Restricted Substances
PURSUANT to clauses 166 and 167 of the Poisons and Therapeutic Goods Regulation 2002, I, KANAN GANDECHA, Acting Chief Pharmacist, a duly appointed delegate of the Director-General of the Department of Health, do hereby grant AUTHORITY to registered nurses, hereby specified as a class of persons, to supply those poisons and restricted substances listed in the Schedule hereunder either singly or in combination, pursuant to clauses 16 and 52 of that Regulation and subject to the following conditions:
-
the nurse is employed in connection with a vaccination program in a health service or a place of work; and
-
the nurse administers a vaccine only in connection with that vaccination program; and
-
the nurse has successfully completed
-
the New South Wales Health Department Immunisation Accreditation Program for Registered Nurses, prior to 2001; and/or
-
the immunisation education program administered by the New South Wales College of Nursing, from 2001; and/or
-
an interstate or overseas immunisation education program that conforms to the National Guidelines for Immunisation Education for Registered Nurses and as approved by the NSW College of Nursing; and
-
-
the nurse administers tuberculin purified protein derivative for tuberculosis skin testing and tuberculosis vaccine only if they have completed additional education in the use of these substances and only if the nurse's record of education states that this additional education has been completed; and
-
the storage, pre-vaccination assessment and administration of each vaccine is at all times undertaken in accordance with the procedures specified in the National Health and Medical Research Council's The Australian Immunisation Handbook, as in force from time to time; and
-
during each vaccination program the nurse carries adrenaline for use in the treatment of anaphylaxis; and
-
administration of adrenaline is at all times undertaken in accordance with the procedures specified in the National Health and Medical Research Council's The Australian Immunisation Handbook, as in force from time to time; and
-
the nurse reports an Adverse Event Following Immunisation (AEFI) to the local Public Health Unit, as required under the NSW Public Health Act 1991; and
-
the nurse ensures that a medical practitioner is contactable for medical advice at all times during the vaccination program; and
-
to maintain authority to immunise, the nurse annually reviews best practice policy for immunisation. This may be, but is not limited to, attendance at updates or seminars on current practices. A statement of proficiency in cardio-pulmonary resuscitation must also be obtained.
SCHEDULE
adrenaline
diphtheria vaccine
haemophilus influenzae Type B (Hib) vaccine
hepatitis A vaccine
hepatitis B vaccine
diphtheria vaccine
haemophilus influenzae Type B (Hib) vaccine
hepatitis A vaccine
hepatitis B vaccine
human papillomavirus vaccine
influenza vaccine
measles-mumps-rubella vaccine
meningococcal vaccine
pertussis vaccine
pneumococcal vaccine
poliomyelitis vaccine
influenza vaccine
measles-mumps-rubella vaccine
meningococcal vaccine
pertussis vaccine
pneumococcal vaccine
poliomyelitis vaccine
rotavirus vaccine
rubella vaccine
tetanus vaccine
tuberculin purified protein derivative
tuberculosis vaccine
varicella vaccine
rubella vaccine
tetanus vaccine
tuberculin purified protein derivative
tuberculosis vaccine
varicella vaccine
Previous authorisations to supply restricted substances dated 15 July 2005, 29 May 2007 and 6 May 2008 published in the New South Wales Government Gazette Nos. 94, 76 and 50 respectively, are hereby revoked.
KANAN GANDECHA,
Acting Chief Pharmacist
Department of Health, New South Wales
Sydney, 4 June 2008.
This web page is managed and authorised by AIDS & Infectious Diseases of Centre for Health Protection of the NSW Department of Health. Last updated: 31 March, 2009
